We have collected information about Drug Delivery Strategies For Therapy Of Visceral Leishmaniasis for you. Follow the links to find out details on Drug Delivery Strategies For Therapy Of Visceral Leishmaniasis.
https://www.researchgate.net/profile/Swati_Gupta32/publication/41759257_Drug_delivery_strategies_for_therapy_of_visceral_leishmaniasis/links/5583c73408ae8bf4ba6fa533/Drug-delivery-strategies-for-therapy-of-visceral-leishmaniasis.pdf
delivery can result in more efficient strategies for the therapy of VL. Keywords: active targeting, colloidal carriers, passive targeting, visceral leishmaniasis Expert Opin. Drug Deliv.
https://www.tandfonline.com/doi/abs/10.1517/17425240903548232
(2010). Drug delivery strategies for therapy of visceral leishmaniasis. Expert Opinion on Drug Delivery: Vol. 7, No. 3, pp. 371-402.Author: Swati Gupta, Ajay Pal, Suresh P Vyas
https://www.researchgate.net/publication/41759257_Drug_delivery_strategies_for_therapy_of_visceral_leishmaniasis
Drug delivery strategies for therapy of visceral leishmaniasis Article · Literature Review (PDF Available) in Expert Opinion on Drug Delivery 7(3):371-402 · March 2010 with 239 Reads
https://www.sciencedirect.com/science/article/pii/S1359644613002687
The conventional treatment schedule for visceral leishmaniasis suffers from a lot of problems like invasive route of administration (parenteral), long treatment course, severe toxicity (nephrotoxicity, cardiotoxicity, among others), high cost of treatment, few treatment regimens, emergence of resistance and variable patient response 2, 13. Thus there is continuous need for new treatment strategy, vaccine candidates …Author: Keerti Jain, Narendra K. Jain
https://www.academia.edu/3353384/Drug_delivery_strategies_for_therapy_of_visceral_leishmaniasis
Drug delivery strategies for therapy of visceral leishmaniasis
https://www.sciencedirect.com/science/article/pii/S1773224719317885
The first-line drugs used to leishmaniasis treatment is an intravenous, intralesional or intramuscular administration of pentavalent antimonials as meglumine antimoniate and sodium stibogluconate (SSG) [7,9,14,15,19].The mechanism of action of these compounds is still not properly understood, but the drugs can inhibit glycolysis step of metabolism and fatty acid oxidation of the parasite [4,7 ...Author: A.P.S. Matos, A.P.S. Matos, A.L. Viçosa, M.I. Ré, E. Ricci-Júnior, C. Holandino
https://www.mysciencework.com/publication/show/cutaneous-leishmaniasis-skin-barrier-properties-drug-delivery-strategies-fa5b066f
Cutaneous Leishmaniasis - Skin Barrier Properties And Drug Delivery Strategies: Cutaneous leishmaniasis (CL) is a parasitic disease caused by several species of Cutaneous leishmaniasis (CL) is a parasitic disease caused by several species of the protozoan parasite Leishmania and affects approximately 10 million people worldwide.
https://www.researchgate.net/publication/313791628_Nanotechnological_Strategies_for_Treatment_of_Leishmaniasis-A_Review
A possibility to improve leishmaniasis treatment would be the application of nanotechnology-drug delivery systems which can enhance the therapeutic potency of existing drugs by optimizing their...
https://www.researchgate.net/publication/41577802_Combination_therapy_for_visceral_leishmaniasis
Combination therapy for the treatment of visceral leishmaniasis has increasingly been advocated as a way to increase treatment efficacy and tolerance, reduce treatment duration and cost, and limit ...
https://www.drugs.com/condition/leishmaniasis.html
43 rows · Drugs Used to Treat Leishmaniasis The following list of medications are in some way related …
Searching for Drug Delivery Strategies For Therapy Of Visceral Leishmaniasis?
You can just click the links above. The data is collected for you.
